Parkinson

2 stories about Parkinson
מימין עודד ליברמן מנכל נוירודרם עם נציגי הרוכשת מיצובישי טנאבה

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm

19.10.17|Lilach Baumer
NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
עובדי נוירודרם

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion

25.07.17|Gil Kalian
Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020